We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+34.24%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$440M
AUM Growth
-$23M
(-5%)
Cap. Flow
-$85M
Cap. Flow
% of AUM
-19.33%
Top 10 Holdings %
Top 10 Hldgs %
9.29%
Holding
714
New
185
Increased
83
Reduced
117
Closed
329
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hyliion Holdings
HYLN
|
+$6.19M |
| 2 |
Alibaba
BABA
|
+$4.16M |
| 3 |
BBBY
Bed Bath & Beyond
BBBY
|
+$3.89M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.7M |
| 5 |
Inovio Pharmaceuticals
INO
|
+$3.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$5.49M |
| 2 |
Walmart Inc
WMT
|
+$4.27M |
| 3 |
Nike
NKE
|
+$4.19M |
| 4 |
Morgan Stanley
MS
|
+$3.37M |
| 5 |
SPWR
SunPower Corporation Common Stock
SPWR
|
+$3.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.73% |
| 2 | Consumer Discretionary | 18.37% |
| 3 | Healthcare | 14.91% |
| 4 | Financials | 9.97% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERN
126
DELISTED
Cerner Corp
CERN
| $1.27M | 0.29% |
+16,200
| New | +$1.2M |
|
|
GBT
127
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.25M | 0.28% |
28,904
-6,539
| -18% | -$322K |
|
128
Consolidated Edison
ED
$39.8B
| $1.25M | 0.28% |
+17,300
| New | +$1.34M |
|
129
West Pharmaceutical
WST
$24.5B
| $1.25M | 0.28% |
+4,400
| New | +$1.23M |
|
|
SINA
130
DELISTED
Sina Corp
SINA
| $1.22M | 0.28% |
28,725
-16,775
| -37% | -$721K |
|
|
BNY
131
Bank of New York Mellon
BNY
$106B
| $1.21M | 0.28% |
+28,500
| New | +$1.09M |
|
132
Graco
GGG
$13B
| $1.21M | 0.27% |
16,700
-16,800
| -50% | -$1.12M |
|
133
EOG Resources
EOG
$77.6B
| $1.21M | 0.27% |
24,204
-18,500
| -43% | -$804K |
|
134
Vertiv
VRT
$101B
| $1.21M | 0.27% |
64,669
+48,100
| +290% | +$885K |
|
135
Quest Diagnostics
DGX
$25.6B
| $1.19M | 0.27% |
9,980
+2,100
| +27% | +$256K |
|
|
OPTU
136
Optimum Communications Inc
OPTU
$336M
| $1.17M | 0.27% |
30,979
-900
| -3% | -$28.2K |
|
|
WWE
137
DELISTED
World Wrestling Entertainment
WWE
| $1.17M | 0.27% |
24,417
-11,000
| -31% | -$462K |
|
138
NiSource
NI
$21.3B
| $1.16M | 0.26% |
50,400
-18,500
| -27% | -$433K |
|
139
Arrowhead Research
ARWR
$12.1B
| $1.15M | 0.26% |
15,030
-181
| -1% | -$11.6K |
|
140
Sabre
SABR
$779M
| $1.15M | 0.26% |
95,761
+19,392
| +25% | +$179K |
|
141
Veritone
VERI
$103M
| $1.15M | 0.26% |
+40,400
| New | +$699K |
|
142
Petrobras
PBR
$123B
| $1.13M | 0.26% |
+100,754
| New | +$894K |
|
143
Crown Holdings
CCK
$13B
| $1.13M | 0.26% |
+11,269
| New | +$1.04M |
|
144
Fulgent Genetics
FLGT
$500M
| $1.13M | 0.26% |
+21,624
| New | +$904K |
|
|
BKI
145
DELISTED
Black Knight, Inc. Common Stock
BKI
| $1.12M | 0.26% |
+12,700
| New | +$1.15M |
|
146
FuelCell Energy
FCEL
$1.71B
| $1.11M | 0.25% |
+3,307
| New | +$541K |
|
147
Micron Technology
MU
$937B
| $1.09M | 0.25% |
+14,500
| New | +$874K |
|
148
PagerDuty
PD
$856M
| $1.08M | 0.25% |
+25,999
| New | +$886K |
|
149
C.H. Robinson
CHRW
$17.3B
| $1.08M | 0.25% |
11,500
+2,000
| +21% | +$191K |
|
150
Teradyne
TER
$57.3B
| $1.08M | 0.25% |
8,984
-9,200
| -51% | -$940K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2020 Portfolio in Review
As of Q4 2020, Seven Eight Capital held 714 positions worth $440M, down 5% from $463M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Seven Eight Capital withdrew a net $85M in Q4 2020, closing 329 positions and reducing 117 holdings. Its most notable exit was Cigna, an estimated $5.49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Hyliion Holdings worth $4.48M.
- Seven Eight Capital's largest Q4 2020 buy was Hyliion Holdings: 271,916 shares worth $4.48M.
- Seven Eight Capital added most to Bed Bath & Beyond in Q4 2020, an estimated $3.89M increase.
- Seven Eight Capital's biggest Q4 2020 reduction was Walmart Inc, cutting an estimated $4.27M.
- Seven Eight Capital fully exited Cigna in Q4 2020, selling an estimated $5.49M.
- Seven Eight Capital's ten largest holdings make up 9.3% of its $440M portfolio in Q4 2020.
- Seven Eight Capital opened 185 new positions and closed 329 in Q4 2020.
- Seven Eight Capital's portfolio value fell 5% quarter-over-quarter to $440M.
Based on Seven Eight Capital's 13F filing for Q4 2020, filed 9 Feb 2021.